Amniotic membrane transplantation By Next Biosciences 30 October 2015 Amniotic membrane transplantation may be considered an alternative method for treating persistent epithelial defects and sterile ulceration that are refractory to conventional treatment and before considering treatment by conjunctival flaps or tarsorrhaphy.
Dry eye decision tree – 10 years after DEWS By Jason Schmit, OD 21 February 2017 The first step in developing the most appropriate treatment plan for a patient with dry eye disease (DED) is to correctly categorise the stage and type of DED the patient exhibits using the available technology. Then address the patient’s symptoms using the appropriate evidence-based therapies.
Biological reasons for the discordance of Monosomy X By Next Biosciences 01 December 2016 While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.
Innovative wound-healing technique using amniotic membrane By Next Biosciences 13 July 2016 According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.
Application of umbilical cord serum eyedrops for dry eye syndrome By Next Biosciences 04 November 2015 Umbilical cord serum contains essential tear components, and umbilical cord serum eyedrops are effective and safe for treating severe dry eye syndrome.
Comparison of autologous serum and umbilical cord serum eye drops By Next Biosciences 04 November 2015 To compare the therapeutic effect between autologous serum and umbilical cord serum eye drops in treating severe dry eye syndrome.
Translational use of Wharton’s jelly In repairing cleft lip and palate By Dr Yvonne Holt 31 July 2017 Explore the potential of Wharton's jelly in the repair of cleft palates, and how it could revolutionise current surgical approaches.
Stem cell revolution By Next Biosciences 18 January 2017 We are at the cusp of a stem cell revolution. Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.
Stem cell storage: Invest in your family’s future health By Dr Nick Walker 11 January 2017 Stem cells are a type of cell that holds the potential to differentiate into different cell types and self-renew. The interest in stem cells in the medical field is at an all-time high.
Sibling Cord Blood Therapy for Cerebral Palsy By Dr Yvonne Holt 24 March 2016 Children with cerebral palsy can now be treated with sibling cord blood therapy.
The loss of a life unlived: Why do miscarriages happen? By Mandy Rodrigues 16 May 2023 After losing a pregnancy, there are many unanswered questions. As humans, we may want answers because that helps us navigate the future with more certainty.
Benefits of Non-Invasive Prenatal Testing (NIPT) By Next Biosciences 12 April 2023 NIPT has increasingly become part of routine prenatal screening due to its many benefits.
Genetic testing of Products of Conception (POCs) By Jaysen Knezovich 23 March 2017 Chromosomal aneuploidies are the most common cause of first-trimester miscarriage, accounting for approximately 50% of spontaneous abortions.
A case for newborn screening in South Africa By Dr Yvonne Holt 22 March 2017 Newborn screening is a worldwide recognised public health measure aimed at the early screening, diagnosis and management of selected metabolic diseases.
A healthy pregnancy starts with a healthy embryo By Jaysen Knezovich 10 March 2017 Discover how pre-implantation genetic screening can reduce the risk of miscarriage and genetic conditions during IVF.
Introducing FirstScreen: The revolutionary newborn screening test By Next Biosciences 01 December 2016 Next Biosciences’ role in developing FirstScreen with North-West University is to establish a newborn screening programme that is widely accessible to South African doctors and patients.
Co-transplantation of umbilical cord tissue MSCs By Next Biosciences 01 December 2016 Exciting clinical work continues in transplant medicine and mesenchymal stem cell therapy. Recent studies from China highlight the co-transplantation of umbilical cord mesenchymal stem cells (UC-MSC) and umbilical cord blood haematopoietic stem cells (CB-HSC).
What you don’t know about newborn screening By 13 October 2016 Act now to give your baby the best chance for a healthy future. Learn about newborn screening and how it can detect serious conditions early on.
Introducing ‘Families of Hope’ from Netcells By Next Biosciences 05 September 2016 We started discussing the form our corporate social investment would take well over a year ago.
Brain injury stem cell therapy advances By Dr Michelle Mason 20 July 2016 There enormous growth in perinatal stem cell research, particularly the non-haematological uses of both cord blood and cord tissue stem cells.
HLA matching embryos for the potential treatment of life-threatening conditions By Jaysen Knezovich 20 July 2016 Current academic views on cord blood banking are still conservative as the lifetime likelihood of developing a blood-related disease requiring transplantation remains low.
A second Netcells baby heads to the US for stem cell treatment By Next Biosciences 12 July 2016 Our Netcells team is proud to announce that we have released a second unit of umbilical cord blood belonging to a three-year-old Netcells baby born with cerebral palsy.
July is Cord Blood Awareness Month By Next Biosciences 07 July 2016 Expectant parents are faced with a number of decisions before the birth of a baby, among them whether to collect the baby’s umbilical cord blood at birth.
Next Biosciences and Genesis, Genetics South Africa combine their DNA By Next Biosciences 20 May 2016 The merger of local leaders in stem cell banking and genetic testing consolidates their position in the African biotechnology industry.
Next Biosciences offers FirstScreen By 20 April 2016 A newborn screening test is done in collaboration with North-West University and includes tests relevant to the South African population.
Next Biosciences’ donation to CHOC By Next Biosciences 16 April 2016 Next Biosciences will work closely with CHOC to ensure that any unutilised funds from procedural fees donated by obstetricians will be directed to CHOC, as the Netcells ‘Families of Hope’ programme’s goals are closely aligned to theirs: Keeping more than hope alive.
Next Biosciences’ Dr Nick Walker is off to Silicon Valley By 11 April 2016 Winner of first South African Global Impact Competition presents an innovative concept to address HIV/AIDS.
Use of autologous adipose-derived mesenchymal stem cells for ovarian rejuvenation By Dr Yvonne Holt 22 May 2023 Advances in adult stem cell research and their clinical application prompted interest in their use in assisted reproduction.
Next Biosciences partners with save the cord foundation By Charis Ober 10 February 2016 Cord blood stem cells are currently being used to treat 80+ diseases, including many blood cancers like leukaemia and lymphoma.
Second autologous transplant for aplastic anaemia successful By Dr Michelle Mason 29 January 2016 Second autologous transplant for aplastic anaemia successful
Application of umbilical cord serum eyedrops for Neurotrophic Keratitis By Next Biosciences 04 November 2015 Application of umbilical cord serum eyedrops for the treatment of Neurotrophic Keratitis
Amniotic membrane transplantation By Next Biosciences 30 October 2015 Amniotic membrane transplantation may be considered an alternative method for treating persistent epithelial defects and sterile ulceration that are refractory to conventional treatment and before considering treatment by conjunctival flaps or tarsorrhaphy.